吉非贝齐可降低患有代谢综合征致动脉粥样硬化血脂异常的腹型肥胖男性的血浆C反应蛋白水平。 - Suppr

Gemfibrozil reduces plasma C-reactive protein levels in abdominally obese men with the atherogenic dyslipidemia of the metabolic syndrome.

作者信息

Després Jean-Pierre, Lemieux Isabelle, Pascot Agnès, Alméras Natalie, Dumont Martine, Nadeau André, Bergeron Jean, Prud'homme Denis

出版信息

Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):702-3. doi: 10.1161/01.ATV.0000062990.62034.64.

DOI:10.1161/01.ATV.0000062990.62034.64

PMID:12692010

Abstract

摘要

相似文献

Gemfibrozil reduces plasma C-reactive protein levels in abdominally obese men with the atherogenic dyslipidemia of the metabolic syndrome.吉非贝齐可降低患有代谢综合征致动脉粥样硬化血脂异常的腹型肥胖男性的血浆C反应蛋白水平。

Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):702-3. doi: 10.1161/01.ATV.0000062990.62034.64.

Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病肥胖患者的代谢和炎症特征

Chron Respir Dis. 2008;5(1):35-41. doi: 10.1177/1479972307087205.

Postprandial variations of plasma inflammatory markers in abdominally obese men.腹型肥胖男性血浆炎症标志物的餐后变化

Obesity (Silver Spring). 2006 Oct;14(10):1747-54. doi: 10.1038/oby.2006.201.

Effect of fenofibrate on adiponectin and inflammatory biomarkers in metabolic syndrome patients.非诺贝特对代谢综合征患者脂联素及炎症生物标志物的影响。

Obesity (Silver Spring). 2009 Mar;17(3):504-9. doi: 10.1038/oby.2008.530. Epub 2008 Nov 20.

Tumor necrosis factor-alpha is a marker of familial combined hyperlipidemia, independently of metabolic syndrome.肿瘤坏死因子-α是家族性混合性高脂血症的一个标志物，独立于代谢综合征。

Metabolism. 2008 Apr;57(4):563-8. doi: 10.1016/j.metabol.2007.11.021.

A randomized trial of the effect of statin and fibrate therapy on arterial function in CKD.一项关于他汀类药物和贝特类药物治疗对慢性肾脏病患者动脉功能影响的随机试验。

Am J Kidney Dis. 2007 Jun;49(6):776-85. doi: 10.1053/j.ajkd.2007.03.003.

Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome.三维人体扫描仪的应用：代谢综合征患病率观察

Clin Nutr. 2004 Dec;23(6):1313-23. doi: 10.1016/j.clnu.2004.04.005.

Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women.高敏C反应蛋白、白细胞介素-6、肿瘤坏死因子-α和纤维蛋白原与健康绝经后女性腹部脂肪组织、血压以及胆固醇和甘油三酯水平的关系。

Am J Cardiol. 2005 Jul 1;96(1):92-7. doi: 10.1016/j.amjcard.2005.02.051.

Management of atherogenic dyslipidemia of the metabolic syndrome: evolving rationale for combined drug therapy.代谢综合征致动脉粥样硬化性血脂异常的管理：联合药物治疗的理论依据演变

Endocrinol Metab Clin North Am. 2004 Sep;33(3):525-44, vi. doi: 10.1016/j.ecl.2004.03.013.

Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin.代谢综合征、胰岛素抵抗以及炎症标志物C反应蛋白和铁蛋白。

Eur J Clin Nutr. 2006 Jun;60(6):802-9. doi: 10.1038/sj.ejcn.1602384. Epub 2006 Feb 22.

引用本文的文献

Exploration of metformin-based drug combination for mitigating diabetes-associated atherosclerotic diseases.探索基于二甲双胍的药物组合以减轻糖尿病相关的动脉粥样硬化疾病。

World J Diabetes. 2025 Apr 15;16(4):100533. doi: 10.4239/wjd.v16.i4.100533.

Evidence Based Laboratory Medicine in the Diagnosis of Metabolic Syndrome.循证检验医学在代谢综合征诊断中的应用

EJIFCC. 2007 Feb 26;18(1):47-54. eCollection 2007 Feb.

Peroxisome Proliferator-Activated Receptor-α Agonism With Fenofibrate Does Not Suppress Inflammatory Responses to Evoked Endotoxemia.非诺贝特激活过氧化物酶体增殖物激活受体-α作用并不抑制内毒素血症诱导的炎症反应。

J Am Heart Assoc. 2012 Aug;1(4):e002923. doi: 10.1161/JAHA.112.002923. Epub 2012 Aug 24.

Gemfibrozil and its combination with metformin on pleiotropic effect on IL-10 and adiponectin and anti-atherogenic treatment in insulin resistant type 2 diabetes mellitus rats.吉非贝齐及其与二甲双胍联合应用对胰岛素抵抗型 2 型糖尿病大鼠 IL-10 和脂联素的多效性作用及抗动脉粥样硬化治疗。

Inflammopharmacology. 2013 Apr;21(2):137-45. doi: 10.1007/s10787-012-0154-4. Epub 2012 Oct 31.

Only C-reactive protein, but not TNF-α or IL6, reflects the improvement in inflammation after bariatric surgery.只有 C 反应蛋白，而不是 TNF-α 或 IL6，反映了减重手术后炎症的改善。

Obes Surg. 2012 Jan;22(1):131-9. doi: 10.1007/s11695-011-0546-3.

Novel markers of peripheral arterial disease.外周动脉疾病的新型标志物。

Vasc Med. 2009 Nov;14(4):381-92. doi: 10.1177/1358863X09106869.

Peroxisome proliferator-activated receptor agonists: do they increase cardiovascular risk?过氧化物酶体增殖物激活受体激动剂：它们会增加心血管风险吗？

PPAR Res. 2009;2009:460764. doi: 10.1155/2009/460764. Epub 2009 Aug 19.

New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor.动脉内膜中C反应蛋白（CRP）沉积作为心血管危险因素的新证据。

Clin Interv Aging. 2008;3(2):341-9. doi: 10.2147/cia.s2706.

Association of common C-reactive protein (CRP) gene polymorphisms with baseline plasma CRP levels and fenofibrate response: the GOLDN study.常见C反应蛋白（CRP）基因多态性与基线血浆CRP水平及非诺贝特反应的关联：GOLDN研究

Diabetes Care. 2008 May;31(5):910-5. doi: 10.2337/dc07-1687. Epub 2008 Feb 19.

Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a review.非诺贝特：一种用于治疗脂质紊乱的新型制剂（力平之）：综述

Int J Nanomedicine. 2006;1(2):129-47. doi: 10.2147/nano.2006.1.2.129.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Gemfibrozil reduces plasma C-reactive protein levels in abdominally obese men with the atherogenic dyslipidemia of the metabolic syndrome.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献